Company Information

  

Address: 373 INVERNESS PARKWAY
SUITE 200 
City: ENGLEWOOD 
State: CO 
Zip Code: 80112 
Telephone: 720-437-6500 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a biopharmaceutical company focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. Our product portfolio is primarily based on the work of Dr. David Bar-Or, the Director of Trauma Research LLC for the Swedish Medical Center located in Englewood, CO, St. Anthony Hospital located in Lakewood, CO and the Medical Center of Plano, Plano Texas. For over two decades, while directing these trauma research laboratories, Dr. Bar-Or and his staff have built a robust portfolio of product candidates focusing on inflammatory conditions. Our initial clinical programs were selected from Dr. Bar-Or's research based on certain criteria, particularly the ability to advance the candidates rapidly into late-stage clinical trials.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/2017-0.20NAN/E
06/2017-0.21NAN/E
03/2017-0.26NAN/E
12/2016-0.36NAN/E
06/2016-0.77NAN/E
03/2016-0.78NAN/E
12/2015-0.55NAN/E
09/2015-0.54NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.12Total Liab/Total Assets0.51
Net Inc/Total Assets-1.41Total Liab/Inv Cap0.61
Net Inc/Inv Cap-1.67Total Liab/Comm Equity0.04
Pretax Inc/Net SalesNAInterest Coverage RatioNA
Net Inc/Net SalesNACurr Debt/EquityNA
Cash Flow/Net SalesNALTD/Equity0.64
SG&A/NetSalesNATotal Debt/Equity0.64
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio2.53
Inventory TurnoverNACurrent Ratio2.53
Inventory Day SalesNANet Rec/Curr AssetsNA
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  9/30/2017 6/30/2017 3/31/2017 12/31/2016
Total Revenues(Net Sales) NA NA NA NA
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 1.07 1.34 1.36 1.31
Operating Income -3.07 -4.69 -3.00 -2.95
Interest Exp NA NA NA NA
Pretax Income -4.25 -2.61 -1.90 -3.35
Other Income -1.19 2.08 1.10 -0.41
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -4.25 -2.61 -1.90 -3.35

Balance Sheet (Millions)

Assets 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Cash & Short Term Investments 1.83 5.00 2.35 5.02
Receivables - Total NA NA NA 0.00
Inventories - Total NA NA NA NA
Total Current Assets 2.25 5.64 2.97 5.40
Net Property, Plant & Equipment 7.10 7.39 7.69 7.98
Total Assets 9.39 13.07 10.84 13.60
Liabilities        
Accounts Payable 2.21 3.09 2.07 2.07
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 2.27 3.15 2.13 2.13
Long-Term Debt 6.76 5.62 3.11 4.24
Total Liabilities 9.59 9.33 5.82 6.96
Stockholder's Equity        
Minority Interest NA NA NA 0.00
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.01 0.01 0.01 0.01
Retained Earnings -161.86 -157.61 -155.00 -153.08
Treasury Stock NA NA NA NA
Total Stockholders' Equity -0.20 3.73 5.02 6.63
Total Liabilities and Stockholders' Equity 9.39 13.07 10.84 13.60

Cash Flow Summary (Millions)

Categories 9/30/2017 6/30/2017 3/31/2017 12/31/2016
Net Cash Provided by Operating Activities -3.13 -3.09 -2.62 -2.58
Net Cash Provided by Investing Activities -0.02 0.00 -0.02 -0.01
Net Cash Provided by Financing Activities 0.01 5.77 0.00 0.07

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20120.05-11.59-0.30
12/20130.05-24.01-0.56
12/20140.00-38.13-0.67
12/20150.00-32.01-0.55
12/20160.00-19.16-0.36
Growth Rates-100.00----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17616,9209.11




Report Date : 12/4/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.